Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Hemophilia”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Not applicableStudy completedNCT02634723
What this trial is testing

Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 21
Not applicableUnknownNCT01505946
What this trial is testing

Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With Inhibitors

Who this might be right for
Severe Hemophilia A With Inhibitor
Grifols Italia S.p.A 25
Testing effectiveness (Phase 2)Looking for participantsNCT04676048
What this trial is testing

ASC618 Gene Therapy in Hemophilia A Patients

Who this might be right for
Hemophilia A
ASC Therapeutics 12
Large-scale testing (Phase 3)Study completedNCT00189982
What this trial is testing

Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101

Who this might be right for
Hemophilia A
Baxalta now part of Shire 4
Large-scale testing (Phase 3)Study completedNCT03569891
What this trial is testing

HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients

Who this might be right for
Hemophilia B
CSL Behring 67
Not applicableUnknownNCT03237273
What this trial is testing

HEAD-US SCORING SYSTEM: Assessment of the Real-world Impact of Ultrasound

Who this might be right for
Moderate and Severe Haemophilia
Guy's and St Thomas' NHS Foundation Trust 200
Not applicableStudy completedNCT00936845
What this trial is testing

Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study

Who this might be right for
Hemophilia AHemophilia B
Weill Medical College of Cornell University 22
Not applicableLooking for participantsNCT05022459
What this trial is testing

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

Who this might be right for
Hemophilia A
Wayne State University 72
Not applicableUnknownNCT02282410
What this trial is testing

Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A

Who this might be right for
Hemophilia A
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 15
Not applicableUnknownNCT05628558
What this trial is testing

Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A

Who this might be right for
Hemophilia A, MildDesmopressinFactor VIII
Groupe Maladies hémorragiques de Bretagne 800
Not applicableStudy completedNCT00195221
What this trial is testing

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

Who this might be right for
Hemophilia BAllergic Reactions
Wyeth is now a wholly owned subsidiary of Pfizer 166
Not applicableStudy completedNCT02035384
What this trial is testing

Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 69
Large-scale testing (Phase 3)Study completedNCT01488994
What this trial is testing

BAX 326 Pediatric Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 23
Not applicableStudy completedNCT03623295
What this trial is testing

The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B

Who this might be right for
Hemophilia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 304
Large-scale testing (Phase 3)Study completedNCT03587116
What this trial is testing

Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

Who this might be right for
Hemophilia BHemophilia A
Pfizer 212
Early research (Phase 1)Study completedNCT02035605
What this trial is testing

An Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients

Who this might be right for
Hemophilia AHemophilia B
Sanofi 51
Not applicableStudy completedNCT04024176
What this trial is testing

Gait Analysis in Moderate Hemophiliac Patients (AQM-Hemophile)

Who this might be right for
Moderate HemophiliaArthropathy
Nantes University Hospital 24
Large-scale testing (Phase 3)Study completedNCT01335061
What this trial is testing

Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 25
Post-approval studies (Phase 4)Study completedNCT00571584
What this trial is testing

High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 24
Large-scale testing (Phase 3)Study completedNCT04158648
What this trial is testing

Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

Who this might be right for
Mild Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHemophilia A
Hoffmann-La Roche 73
Next Page